← Open Payments lookup

KATIE ROBINSON: Open Payments

NPI 1598400053 · LYNCHBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,191 in 45 payments from 12 companies in 2025. Trend: 2023 $31 · 2024 $86 · 2025 $1,191

Food & beverage: $894Education: $297
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP14$271
Regeneron Healthcare Solutions, Inc.7$238
SANOFI-AVENTIS U.S. LLC2$199
GENZYME CORPORATION6$159
Novartis Pharmaceuticals Corporation6$122
Genentech USA, Inc.3$70
ARS Pharmaceuticals Operations, Inc.1$30
Takeda Pharmaceuticals U.S.A., Inc.2$29
Verona Pharma, Inc.1$23
GlaxoSmithKline, LLC.1$17

Products named: DUPIXENT, AIRSUPRA, Xolair, BREZTRI, Rhapsido, FASENRA, NEFFY, TAKHZYRO.

Industry payments across VA — which companies pay providers there.